Industry Asks For Clarity On LDC Request To Extend TRIPS Pharma Waiver 01/05/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment Least developed countries (LDCs) at the World Trade Organization have requested that a waiver allowing them to not enforce intellectual property rights on pharmaceutical products be extended beyond its deadline of 1 January 2016. The brand pharmaceutical industry this week stated that it supports access to medicines for LDCs but does not see the need for this extension as LDCs already benefit from a WTO waiver on all products until 2021.
Pharma Offers View On How To Slow Antimicrobial Resistance, Boost Research 30/04/2015 by Catherine Saez, Intellectual Property Watch 1 Comment the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) provided its recommendations on how to slow down antimicrobial resistance and boost antibiotic research and development. In addition, the association organised a forum on the subject today.
Chile: Study On Pharma Patents Shows Foreign Ownership 30/04/2015 by Elena Bourtchouladze for Intellectual Property Watch Leave a Comment In Chile, pharmaceutical patents are almost exclusively the domain of foreign companies. Only a subset of drugs is protected by patents, while a much larger number of products is protected by trademarks, a study finds, offering for the first time empirical evidence on the use of primary and secondary patents in Chile.
Positive Note For WIPO Committee On IP And Development, Some Issues Remain 28/04/2015 by Catherine Saez, Intellectual Property Watch 3 Comments At the close of the session of the World Intellectual Property Organization Committee on Development and Intellectual Property (CDIP) last week, delegates left on a positive note. Despite not achieving concrete results on several issues, the meeting was described as encouraging by some participants. Technical assistance remained one of the prickly issues, as well as the mechanism for WIPO committees to report on their implementation of the Development Agenda.
Seminar Discusses Global Value Chains And Development 28/04/2015 by Elena Bourtchouladze for Intellectual Property Watch Leave a Comment Participation in global value chains contributes to economic growth, while trade and trade-related policies, such as foreign direct investment, intellectual property protection, trade facilitation, infrastructure and institutions, together with deeper regional integration have important impacts on global value chain integration in developing countries. This was the view of speakers at a recent event in Geneva.
UAEM Grades US Universities On Research For Neglected Diseases. Spoiler Alert – There’s Room For Improvement 24/04/2015 by William New, Intellectual Property Watch 1 Comment Universities play an enormous role in biomedical research in the United States, but are not doing all they can to advance research for neglected diseases or make their innovations available to people who need them most, the student groupUniversities Allied for Essential Medicines (UAEM) said this week. UAEM released the results of its second annual […]
UN Expert Says Secret Trade Negotiations A Threat To Human Rights 23/04/2015 by Intellectual Property Watch 7 Comments The United Nations independent expert on the promotion of a democratic and equitable international order raised concerns over the lack of awareness about the negative effects that free trade and investment agreements have on human rights, especially in developing countries. The Independent Expert on the promotion of a democratic and equitable international order, Alfred de […]
WIPO CDIP: New Proposals Rekindle Conversation On IP And Development 23/04/2015 by Catherine Saez, Intellectual Property Watch 2 Comments Among the outstanding issues at the World Intellectual Property Organization is how WIPO committees report to the General Assembly on their implementation of the organisation’s Development Agenda Recommendations. At this week’s meeting on the issue, a new proposal submitted by Mexico attempts to breach differences.
WHO Reviews Its Essential Medicines List; Some New Candidates Under Patent 21/04/2015 by Catherine Saez, Intellectual Property Watch 1 Comment The World Health Organization is reviewing its list of essential medicines this week. Over 70 candidate medicines are expected to be assessed by an Expert Committee. Some of those medicines are under patent and highly priced, which poses an accessibility challenge.
WHO Opens Its Database Of Medicines Side Effects To The Public 20/04/2015 by Catherine Saez, Intellectual Property Watch 1 Comment The World Health Organization has announced that its Global Medicines Safety Database is now open to the general public. The database named VigiAccess can now be accessed on any computer or smartphone in the world.